

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.49465142 |
| 2 | * antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.34676495 |
| 3 | * negative regulation of cell killing (GO:0031342) | 6.24742816 |
| 4 | * negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.24742816 |
| 5 | * antigen processing and presentation of endogenous antigen (GO:0019883) | 6.14288727 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.90043767 |
| 7 | * antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.72411498 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.14338827 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.14338827 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.14338827 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.14338827 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.14338827 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.14338827 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.84489057 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.50958397 |
| 16 | * detection of other organism (GO:0098543) | 4.46288906 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.43283543 |
| 18 | leukocyte aggregation (GO:0070486) | 4.42317087 |
| 19 | * detection of bacterium (GO:0016045) | 4.37085569 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.36289701 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.32995189 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 4.23208743 |
| 23 | response to interleukin-15 (GO:0070672) | 4.15790801 |
| 24 | response to peptidoglycan (GO:0032494) | 4.13100013 |
| 25 | negative regulation of interleukin-12 production (GO:0032695) | 4.11521799 |
| 26 | * type I interferon signaling pathway (GO:0060337) | 4.07981860 |
| 27 | * cellular response to type I interferon (GO:0071357) | 4.07981860 |
| 28 | * response to type I interferon (GO:0034340) | 4.05334770 |
| 29 | * negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.94478540 |
| 30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.86784006 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 3.85815151 |
| 32 | negative thymic T cell selection (GO:0045060) | 3.83302896 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.82678502 |
| 34 | cellular extravasation (GO:0045123) | 3.78588904 |
| 35 | negative T cell selection (GO:0043383) | 3.73802252 |
| 36 | respiratory burst (GO:0045730) | 3.69458491 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.68907532 |
| 38 | * detection of external biotic stimulus (GO:0098581) | 3.68605535 |
| 39 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.67248178 |
| 40 | positive thymic T cell selection (GO:0045059) | 3.65150818 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 3.61034217 |
| 42 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.60710527 |
| 43 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.58371116 |
| 44 | neutrophil activation (GO:0042119) | 3.57347737 |
| 45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.52240632 |
| 46 | response to host immune response (GO:0052572) | 3.52240632 |
| 47 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.49677160 |
| 48 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.45833778 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 3.43388160 |
| 50 | T cell migration (GO:0072678) | 3.43001896 |
| 51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.39227885 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.32699986 |
| 53 | B cell mediated immunity (GO:0019724) | 3.32341677 |
| 54 | tolerance induction (GO:0002507) | 3.32284970 |
| 55 | granulocyte activation (GO:0036230) | 3.31456480 |
| 56 | regulation of B cell differentiation (GO:0045577) | 3.31210155 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.30192488 |
| 58 | response to host (GO:0075136) | 3.29397209 |
| 59 | response to host defenses (GO:0052200) | 3.29397209 |
| 60 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.29397209 |
| 61 | germinal center formation (GO:0002467) | 3.29159763 |
| 62 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.28777199 |
| 63 | defense response to protozoan (GO:0042832) | 3.28040492 |
| 64 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.27962452 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.25940832 |
| 66 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.25514475 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 3.24137950 |
| 68 | T cell selection (GO:0045058) | 3.22998859 |
| 69 | thymic T cell selection (GO:0045061) | 3.21185998 |
| 70 | microglial cell activation (GO:0001774) | 3.20772976 |
| 71 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.18521889 |
| 72 | * detection of biotic stimulus (GO:0009595) | 3.18354121 |
| 73 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 3.18305503 |
| 74 | regulation of antigen processing and presentation (GO:0002577) | 3.17273938 |
| 75 | negative regulation of phagocytosis (GO:0050765) | 3.14881820 |
| 76 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.12606348 |
| 77 | positive T cell selection (GO:0043368) | 3.12259788 |
| 78 | NIK/NF-kappaB signaling (GO:0038061) | 3.10965272 |
| 79 | * positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.07115422 |
| 80 | macrophage activation (GO:0042116) | 3.06871514 |
| 81 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.02764817 |
| 82 | regulation of regulatory T cell differentiation (GO:0045589) | 3.02525006 |
| 83 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02145555 |
| 84 | * regulation of natural killer cell mediated immunity (GO:0002715) | 3.01892552 |
| 85 | * regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.01892552 |
| 86 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00418440 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.99772675 |
| 88 | positive regulation of tolerance induction (GO:0002645) | 2.98703456 |
| 89 | response to protozoan (GO:0001562) | 2.98584813 |
| 90 | regulation of leukocyte degranulation (GO:0043300) | 2.96785515 |
| 91 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.96392422 |
| 92 | * regulation of T cell tolerance induction (GO:0002664) | 2.96360112 |
| 93 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.90876056 |
| 94 | positive regulation of mast cell activation (GO:0033005) | 2.90395296 |
| 95 | dendritic cell chemotaxis (GO:0002407) | 2.87698290 |
| 96 | positive regulation of interferon-alpha production (GO:0032727) | 2.87089308 |
| 97 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86058068 |
| 98 | neutrophil mediated immunity (GO:0002446) | 2.85972626 |
| 99 | activated T cell proliferation (GO:0050798) | 2.85805830 |
| 100 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.85279178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.63869646 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.47755640 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.90455608 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.89114301 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.58220349 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.41357946 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.35139977 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.00334901 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.90764894 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.86936823 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.86874436 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66841223 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.62934798 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.57077605 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.55130661 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.55032548 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54197230 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53709220 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.44114179 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42358216 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39235378 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.38415765 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.37281460 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.32794929 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.31064969 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 2.25333237 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.22474640 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.18989344 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.17263702 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.16119699 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.09430715 |
| 32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.07871582 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05496096 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.02319583 |
| 35 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00261657 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.96611992 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92631837 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.91965455 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.87124552 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.80914635 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.79843861 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76409301 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.76081840 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.63871077 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.63741026 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.58638004 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57502837 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55486073 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51672005 |
| 50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50270806 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47202990 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.45859970 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44993825 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43924301 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42628959 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40346123 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34333075 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33629307 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32282453 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29890868 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28493351 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27605987 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23633282 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23366234 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23307486 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23004438 |
| 67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.21082149 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19739122 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18476463 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18336750 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17670135 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17359438 |
| 73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16881107 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16332933 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16270629 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16259565 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.14408131 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13152480 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11605659 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10547999 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10025432 |
| 82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09004234 |
| 83 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05739973 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01479286 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01315402 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99093943 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94766273 |
| 88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94597942 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94551131 |
| 90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94265105 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93892846 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92622213 |
| 93 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92615188 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92394221 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90474988 |
| 96 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89649800 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88142294 |
| 98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86547870 |
| 99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86212432 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85462045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.31891042 |
| 2 | MP0003436_decreased_susceptibility_to | 4.18482033 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.97166828 |
| 4 | MP0003303_peritoneal_inflammation | 3.68528440 |
| 5 | MP0005671_abnormal_response_to | 3.40746027 |
| 6 | MP0005387_immune_system_phenotype | 3.14342117 |
| 7 | MP0001790_abnormal_immune_system | 3.14342117 |
| 8 | MP0001800_abnormal_humoral_immune | 3.11817477 |
| 9 | MP0000685_abnormal_immune_system | 3.08807148 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.00726913 |
| 11 | MP0002419_abnormal_innate_immunity | 2.96380596 |
| 12 | MP0005025_abnormal_response_to | 2.94452602 |
| 13 | MP0009785_altered_susceptibility_to | 2.94329911 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.73616206 |
| 15 | MP0006082_CNS_inflammation | 2.72250289 |
| 16 | MP0002723_abnormal_immune_serum | 2.69869393 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.62635271 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.60486158 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.59756187 |
| 20 | MP0001819_abnormal_immune_cell | 2.57868318 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.40986482 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.16292023 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.08818834 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.08140384 |
| 25 | MP0002405_respiratory_system_inflammati | 2.05945399 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.01694417 |
| 27 | MP0002398_abnormal_bone_marrow | 2.00345061 |
| 28 | MP0000716_abnormal_immune_system | 1.97843776 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.88779588 |
| 30 | MP0004947_skin_inflammation | 1.87465038 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.84675096 |
| 32 | MP0003866_abnormal_defecation | 1.75393160 |
| 33 | MP0008260_abnormal_autophagy | 1.68202676 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.63448989 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.62355562 |
| 36 | MP0002722_abnormal_immune_system | 1.61196482 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.58554972 |
| 38 | MP0002429_abnormal_blood_cell | 1.55788548 |
| 39 | MP0005451_abnormal_body_composition | 1.51692601 |
| 40 | MP0002132_abnormal_respiratory_system | 1.51456179 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.50490738 |
| 42 | MP0008469_abnormal_protein_level | 1.50063123 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.49706871 |
| 44 | MP0005310_abnormal_salivary_gland | 1.48021404 |
| 45 | MP0009278_abnormal_bone_marrow | 1.46647516 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.45398218 |
| 47 | MP0004510_myositis | 1.44314434 |
| 48 | MP0001873_stomach_inflammation | 1.42922587 |
| 49 | MP0000858_altered_metastatic_potential | 1.38580438 |
| 50 | MP0003828_pulmonary_edema | 1.35105276 |
| 51 | MP0009764_decreased_sensitivity_to | 1.34937118 |
| 52 | MP0005058_abnormal_lysosome_morphology | 1.33066450 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.30040400 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.29316637 |
| 55 | MP0001851_eye_inflammation | 1.25311577 |
| 56 | MP0004381_abnormal_hair_follicle | 1.24366556 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.19862870 |
| 58 | MP0003075_altered_response_to | 1.17628065 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.13797320 |
| 60 | MP0004883_abnormal_blood_vessel | 1.12810550 |
| 61 | MP0005166_decreased_susceptibility_to | 1.10524698 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.03698852 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.03698852 |
| 64 | MP0001853_heart_inflammation | 1.01095344 |
| 65 | MP0002933_joint_inflammation | 1.00607878 |
| 66 | MP0000490_abnormal_crypts_of | 0.98814097 |
| 67 | MP0003448_altered_tumor_morphology | 0.98741856 |
| 68 | MP0003690_abnormal_glial_cell | 0.97943263 |
| 69 | MP0001663_abnormal_digestive_system | 0.95141914 |
| 70 | MP0009840_abnormal_foam_cell | 0.93806229 |
| 71 | MP0000343_altered_response_to | 0.92820303 |
| 72 | MP0000604_amyloidosis | 0.92620054 |
| 73 | MP0005164_abnormal_response_to | 0.92032623 |
| 74 | MP0005390_skeleton_phenotype | 0.87369469 |
| 75 | MP0009763_increased_sensitivity_to | 0.86981287 |
| 76 | MP0002006_tumorigenesis | 0.83115578 |
| 77 | MP0003045_fibrosis | 0.80281746 |
| 78 | MP0008004_abnormal_stomach_pH | 0.76255240 |
| 79 | MP0003091_abnormal_cell_migration | 0.74554731 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 0.72337800 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 0.71425124 |
| 82 | MP0000249_abnormal_blood_vessel | 0.68952658 |
| 83 | MP0003795_abnormal_bone_structure | 0.68724198 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 0.66766742 |
| 85 | MP0008874_decreased_physiological_sensi | 0.65044544 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.62051325 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.58795543 |
| 88 | MP0005381_digestive/alimentary_phenotyp | 0.55279409 |
| 89 | MP0002254_reproductive_system_inflammat | 0.52541064 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.51314704 |
| 91 | MP0002019_abnormal_tumor_incidence | 0.50597627 |
| 92 | MP0002693_abnormal_pancreas_physiology | 0.49691006 |
| 93 | MP0000609_abnormal_liver_physiology | 0.49258951 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.47584048 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.47547480 |
| 96 | MP0004858_abnormal_nervous_system | 0.46246114 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.45987500 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.45234641 |
| 99 | MP0000920_abnormal_myelination | 0.43657008 |
| 100 | MP0001958_emphysema | 0.42718897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.95457769 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.72759152 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.65466997 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.44497589 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.82627512 |
| 6 | * Myositis (HP:0100614) | 4.80372102 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.68829918 |
| 8 | Stomatitis (HP:0010280) | 4.57824519 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.38382373 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.30468067 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.20618548 |
| 12 | * Orchitis (HP:0100796) | 4.19442410 |
| 13 | * Meningitis (HP:0001287) | 4.12032069 |
| 14 | Obstructive lung disease (HP:0006536) | 4.04047397 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.04047397 |
| 16 | Increased IgE level (HP:0003212) | 3.86249964 |
| 17 | Recurrent skin infections (HP:0001581) | 3.85871508 |
| 18 | * Retrobulbar optic neuritis (HP:0100654) | 3.69722617 |
| 19 | * Optic neuritis (HP:0100653) | 3.69722617 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.64622696 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.64622696 |
| 22 | * Vasculitis (HP:0002633) | 3.63982605 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.62136723 |
| 24 | T lymphocytopenia (HP:0005403) | 3.51981564 |
| 25 | Cellulitis (HP:0100658) | 3.51090743 |
| 26 | Gingivitis (HP:0000230) | 3.47823287 |
| 27 | Urticaria (HP:0001025) | 3.39202772 |
| 28 | Abnormality of T cell number (HP:0011839) | 3.37990668 |
| 29 | Recurrent viral infections (HP:0004429) | 3.35379052 |
| 30 | * Encephalitis (HP:0002383) | 3.34073248 |
| 31 | Panhypogammaglobulinemia (HP:0003139) | 3.17048420 |
| 32 | Inflammation of the large intestine (HP:0002037) | 3.13636214 |
| 33 | Pustule (HP:0200039) | 3.10322717 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 3.06708891 |
| 35 | Increased IgM level (HP:0003496) | 2.99938515 |
| 36 | Abnormality of T cells (HP:0002843) | 2.99759253 |
| 37 | Prolonged bleeding time (HP:0003010) | 2.99645945 |
| 38 | * Pulmonary infiltrates (HP:0002113) | 2.92342428 |
| 39 | Lymphopenia (HP:0001888) | 2.89739650 |
| 40 | Colitis (HP:0002583) | 2.88676784 |
| 41 | * Gastrointestinal infarctions (HP:0005244) | 2.88314194 |
| 42 | Agammaglobulinemia (HP:0004432) | 2.86919763 |
| 43 | Leukocytosis (HP:0001974) | 2.84647603 |
| 44 | Recurrent bronchitis (HP:0002837) | 2.84438794 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.82074293 |
| 46 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.74534873 |
| 47 | Granulocytopenia (HP:0001913) | 2.71949757 |
| 48 | * Chest pain (HP:0100749) | 2.71051052 |
| 49 | * Hemoptysis (HP:0002105) | 2.69850025 |
| 50 | Osteomyelitis (HP:0002754) | 2.69454308 |
| 51 | * Keratoconjunctivitis sicca (HP:0001097) | 2.64516942 |
| 52 | Epistaxis (HP:0000421) | 2.61779365 |
| 53 | Hypergammaglobulinemia (HP:0010702) | 2.61124933 |
| 54 | Episodic fever (HP:0001954) | 2.61099589 |
| 55 | Chronic otitis media (HP:0000389) | 2.60487290 |
| 56 | Petechiae (HP:0000967) | 2.58556982 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.55959281 |
| 58 | Gingival bleeding (HP:0000225) | 2.55252745 |
| 59 | Hypochromic anemia (HP:0001931) | 2.49433293 |
| 60 | IgM deficiency (HP:0002850) | 2.48070497 |
| 61 | Nasal polyposis (HP:0100582) | 2.47197334 |
| 62 | * Keratoconjunctivitis (HP:0001096) | 2.40677323 |
| 63 | Recurrent sinusitis (HP:0011108) | 2.39401787 |
| 64 | Amyloidosis (HP:0011034) | 2.37633894 |
| 65 | Purpura (HP:0000979) | 2.34000572 |
| 66 | Peritonitis (HP:0002586) | 2.32669258 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.30377203 |
| 68 | Abnormality of glycolipid metabolism (HP:0010969) | 2.30377203 |
| 69 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.30377203 |
| 70 | Loss of speech (HP:0002371) | 2.29036046 |
| 71 | Eosinophilia (HP:0001880) | 2.28186932 |
| 72 | Autoimmune hemolytic anemia (HP:0001890) | 2.26374987 |
| 73 | Abnormality of the nasal mucosa (HP:0000433) | 2.25137941 |
| 74 | * Pulmonary embolism (HP:0002204) | 2.24911956 |
| 75 | Premature loss of primary teeth (HP:0006323) | 2.23353374 |
| 76 | * Sepsis (HP:0100806) | 2.20966119 |
| 77 | Systemic lupus erythematosus (HP:0002725) | 2.20345658 |
| 78 | Increased cerebral lipofuscin (HP:0011813) | 2.19761492 |
| 79 | Recurrent pneumonia (HP:0006532) | 2.18274197 |
| 80 | Abnormality of the peritoneum (HP:0002585) | 2.17859748 |
| 81 | Papilloma (HP:0012740) | 2.17580001 |
| 82 | Verrucae (HP:0200043) | 2.17580001 |
| 83 | Emphysema (HP:0002097) | 2.15813783 |
| 84 | Hepatosplenomegaly (HP:0001433) | 2.15153095 |
| 85 | * Skin ulcer (HP:0200042) | 2.15134129 |
| 86 | Malnutrition (HP:0004395) | 2.15088921 |
| 87 | Chronic diarrhea (HP:0002028) | 2.14980165 |
| 88 | * Abnormality of the pleura (HP:0002103) | 2.13680446 |
| 89 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.08589601 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 2.07961560 |
| 91 | Increased serum ferritin (HP:0003281) | 2.07665672 |
| 92 | Skin rash (HP:0000988) | 2.06584406 |
| 93 | * Arterial thrombosis (HP:0004420) | 2.05517081 |
| 94 | Recurrent lower respiratory tract infections (HP:0002783) | 2.04779082 |
| 95 | Viral hepatitis (HP:0006562) | 2.04694198 |
| 96 | * Anorexia (HP:0002039) | 2.04548438 |
| 97 | Hypochromic microcytic anemia (HP:0004840) | 2.02145544 |
| 98 | Joint swelling (HP:0001386) | 2.00410616 |
| 99 | Dysostosis multiplex (HP:0000943) | 1.98085074 |
| 100 | Slow saccadic eye movements (HP:0000514) | 1.97352891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.46062308 |
| 2 | MAP4K1 | 4.34908274 |
| 3 | ERN1 | 3.18510652 |
| 4 | TYK2 | 3.06071362 |
| 5 | PRPF4B | 2.94771604 |
| 6 | IRAK4 | 2.80014622 |
| 7 | BLK | 2.74762633 |
| 8 | CSK | 2.54010330 |
| 9 | MAP2K3 | 2.37515688 |
| 10 | FES | 2.27831923 |
| 11 | ZAP70 | 2.12022659 |
| 12 | TNK2 | 2.08057033 |
| 13 | TXK | 2.04730766 |
| 14 | EPHB1 | 2.01069488 |
| 15 | GRK6 | 1.99087884 |
| 16 | JAK3 | 1.93324747 |
| 17 | MAP3K14 | 1.90013145 |
| 18 | BTK | 1.87411232 |
| 19 | IKBKE | 1.84395047 |
| 20 | TBK1 | 1.75986868 |
| 21 | MAP3K13 | 1.70808330 |
| 22 | SYK | 1.66918517 |
| 23 | JAK1 | 1.65548501 |
| 24 | HCK | 1.65315456 |
| 25 | MAP3K3 | 1.63705034 |
| 26 | TAOK1 | 1.57934096 |
| 27 | SIK3 | 1.57038900 |
| 28 | MAP3K11 | 1.54671359 |
| 29 | FGR | 1.43645620 |
| 30 | LYN | 1.35624977 |
| 31 | TRIB3 | 1.30268486 |
| 32 | JAK2 | 1.30133525 |
| 33 | KIT | 1.24819706 |
| 34 | ITK | 1.23486581 |
| 35 | FGFR4 | 1.22284468 |
| 36 | CSF1R | 1.21252720 |
| 37 | TAOK3 | 1.20903419 |
| 38 | * LCK | 1.20806414 |
| 39 | SMG1 | 1.20351251 |
| 40 | MAP3K1 | 1.18886398 |
| 41 | SIK2 | 1.05308071 |
| 42 | IKBKB | 1.04026335 |
| 43 | MARK3 | 1.03162103 |
| 44 | KSR2 | 1.01015641 |
| 45 | TAOK2 | 0.98015763 |
| 46 | TESK2 | 0.95944815 |
| 47 | STK10 | 0.94398370 |
| 48 | PTK6 | 0.91425301 |
| 49 | MARK2 | 0.89621732 |
| 50 | PRKD2 | 0.89096227 |
| 51 | YES1 | 0.88950434 |
| 52 | MATK | 0.87111005 |
| 53 | CDC42BPA | 0.86927542 |
| 54 | PDK1 | 0.86738911 |
| 55 | TEC | 0.84078925 |
| 56 | FGFR3 | 0.83662155 |
| 57 | SIK1 | 0.81404090 |
| 58 | BMPR2 | 0.79207204 |
| 59 | IRAK1 | 0.78931879 |
| 60 | TGFBR2 | 0.72187095 |
| 61 | PDPK1 | 0.71545308 |
| 62 | MAPK12 | 0.69491312 |
| 63 | HIPK2 | 0.68958949 |
| 64 | PRKCQ | 0.67796050 |
| 65 | EPHA3 | 0.67617671 |
| 66 | LRRK2 | 0.67408314 |
| 67 | MAPK7 | 0.64565736 |
| 68 | FYN | 0.64177359 |
| 69 | MAP3K7 | 0.62195645 |
| 70 | NLK | 0.60036631 |
| 71 | CDK19 | 0.58913605 |
| 72 | IRAK2 | 0.58833328 |
| 73 | MAP3K10 | 0.54139929 |
| 74 | CAMKK1 | 0.51343514 |
| 75 | GRK7 | 0.49716163 |
| 76 | DYRK1B | 0.49490166 |
| 77 | PIM1 | 0.49267620 |
| 78 | MAP3K6 | 0.48646672 |
| 79 | IRAK3 | 0.48042463 |
| 80 | RIPK1 | 0.45313288 |
| 81 | RPS6KL1 | 0.43125098 |
| 82 | RPS6KC1 | 0.43125098 |
| 83 | MAPK11 | 0.42496461 |
| 84 | MAP3K5 | 0.40239011 |
| 85 | RET | 0.40169651 |
| 86 | MAPKAPK2 | 0.38518068 |
| 87 | CDK4 | 0.38140052 |
| 88 | PTK2B | 0.36906942 |
| 89 | STK11 | 0.36847808 |
| 90 | MAP2K6 | 0.36567389 |
| 91 | PRKCH | 0.35658160 |
| 92 | CAMKK2 | 0.35323541 |
| 93 | MAP3K2 | 0.34732569 |
| 94 | RPS6KA6 | 0.33745766 |
| 95 | STK38 | 0.32585934 |
| 96 | SGK3 | 0.32513509 |
| 97 | PRKG2 | 0.29842503 |
| 98 | CHUK | 0.29809553 |
| 99 | MAP3K8 | 0.29208492 |
| 100 | PIK3CG | 0.27408409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Allograft rejection_Homo sapiens_hsa05330 | 3.01071745 |
| 2 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 2.93101303 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90943865 |
| 4 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.81310249 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.78755694 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.74719022 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.70098025 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.30191423 |
| 9 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.19735017 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19731643 |
| 11 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.18175694 |
| 12 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.06448750 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.05143828 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.99330594 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96844444 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.93676482 |
| 17 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.89694605 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.86066157 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83763966 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.81474606 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.76035003 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70989688 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64001240 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.63690605 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.63052685 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57514091 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.55031120 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.54156036 |
| 29 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.53072236 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50138574 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48494216 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47310725 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.36956229 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33502738 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32662802 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27275319 |
| 37 | * Phagosome_Homo sapiens_hsa04145 | 1.26866673 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22103053 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.21625503 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.17875858 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16266301 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.14268166 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.07421534 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04759471 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03817668 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 0.97045804 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 0.94727414 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93775643 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93577848 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.93517093 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91549986 |
| 52 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89994797 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87809265 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 0.87799842 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86702186 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.81023264 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77966874 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77928643 |
| 59 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77813857 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76991301 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75042379 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71287819 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69401777 |
| 64 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68254186 |
| 65 | * Endocytosis_Homo sapiens_hsa04144 | 0.66418459 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64817403 |
| 67 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.64510117 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63959162 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62049872 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60099992 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59096125 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52820314 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52035762 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51722469 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51489064 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50449616 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49267906 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.49135938 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47676147 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.45691865 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45121719 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44812194 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43729494 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43523828 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39145319 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38415999 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38245738 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38134460 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37288504 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37274123 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36871429 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35490331 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35330655 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34442057 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31583293 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31327583 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.29334834 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27509820 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26053735 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22975110 |

